Compass Therapeutics Stock Forecast

Sell candidate since Jul 24, 2026 Loss -7.73%

The Compass Therapeutics, Inc. stock price fell by -1.55% on the last day (Friday, 31st Jul 2026) from $1.94 to $1.91. During the last trading day the stock fluctuated 5.24% from a day low at $1.86 to a day high of $1.96. The price has fallen in 6 of the last 10 days and is down by -6.83% for this period. Volume has increased on the last day by 747 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately $5.04 million.

The stock has broken the very wide and weak rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $2.03. A reaction back to this level may hold a second chance to get out before further falls.

CMPX Signals & Forecast

There are few to no technical positive signals at the moment. The Compass Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.01 and $2.11. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, July 08, 2026, and so far it has fallen -18.38%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Compass Therapeutics, Inc. stock

Compass Therapeutics, Inc. finds support from accumulated volume at $1.87 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0975 between high and low, or 5.24%. For the last week, the stock has had daily average volatility of 5.10%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CMPX) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Compass Therapeutics, Inc. to open at $1.91, and during the day (based on 14 day Average True Range), to move between $1.86 and $1.96, which gives a possible trading interval of +/-$0.109 (+/-5.90%) up or down from last closing price. If Compass Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 5.90% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.94 (1.57%) than the support at $1.87 (2.09%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Compass Therapeutics, Inc. stock A Buy?

The Compass Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Compass Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.813 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $1.91 ( 0.0436%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk